• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

Aortic Centers: The Ideal Way to Collaborate for our Patients

  • Wed, 3/7/12 - 10:48am
  • 9628 reads
  • 0 comments

As some of you know, I recently accepted a position in the Section of Vascular Surgery and Endovascular Therapy at the University of Chicago Medicine. One of my major administrative responsibilities is co-directing the University of Chicago Center for Aortic Diseases (UCCAD – www.ucaorta.org) with Mark Russo, MD, MSc. We have assembled a group of physicians that want to treat the most complex aortic diseases. We hope to establish ourselves as a regional and national center of excellence. Our group includes vascular surgery, cardiac surgery, interventional cardiology, general cardiology, interventional radiology, and anesthesiology/critical care. I think this case illustrates our mission and collaboration well.

We recently cared for a gentleman who underwent a type A aortic dissection repair approximately 5 years ago. He presented to another institution with chest pain and had an aortic pseudoaneurysm in the ascending aorta near the coronary arteries. We performed a diagnostic aortogram, IVUS of the aorta, and cardiac catheterization in the same sitting in the cath lab under the direction of Dr. Sandeep Nathan. A few days later, he underwent a multivessel coronary intervention by Dr. Nathan. He did well and returned 3 weeks later for an endovascular approach to this complex ascending aortic problem.

We treated him in the OR with Dr. Mark Chaney leading our anesthesia team and Dr. Roberto Lang assisting with his expertise in TEE. Dr. Russo and I successfully placed a stent in the ascending aorta with the protection of cardio-pulmonary bypass in case a coronary artery was inadvertently covered. In addition, Dr. Nathan scrubbed in to place a catheter at the origin of the left main to assist with identifying this vessel when we deployed the aortic extension cuff in the ascending aorta (Figures 1 and 2). The patient did very well and was discharged on POD #2 with this approach. A redo sternotomy would have carried a very high morbidity and mortality rate. This approach made a huge difference in outcome for this patient.

IVUS = intravascular ultrasound

TEE = transesophageal echocardiography

OR = operating room

POD #2 = Postoperative Day 2

_______________________________________________________________________________

ROSS MILNER, MD, FACS

Ross Milner, MD, FACS is associate professor of surgery in the section of vascular surgery and endovascular therapy, co-director of the Center for Aortic Diseases, and associate program director of the Vascular Surgery Fellowship at The University of Chicago Medicine & Biological Sciences.

Dr. Milner graduated Cum Laude from the University of Pennsylvania, where he also completed medical school. He was chief resident in surgery at the Hospital of the University of Pennsylvania. He completed fellowships at the University of Pennsylvania and University Medical Center in Utrecht in the Netherlands.

Bookmark/Search this post with
  • Digg
  • LinkedIn
  • Reddit
  • Facebook Like
  • Google Plus One
  • Linkedin Share Button
  • Tweet Widget
Find more blogs image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    Wed, 05/15/13 - 10:12am
  • Reverse Medical Corporation Announces CE Mark and Initial Clinical Experience with the MVP Micro Vascular Plug for Peripheral Embolization
    Wed, 05/15/13 - 8:55am
  • St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
    Wed, 05/15/13 - 8:52am
  • Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
    Tue, 05/14/13 - 10:02am
more »

Clinical Events Calendar

  • New Frontiers in Endovascular Therapy
    Fri, 05/17/2013 - Sat, 05/18/2013
    Jacksonville, FL, United States
  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications